Another busy week at Retraction Watch. Here’s what was happening elsewhere: “Why are dope-addicted, disgraced doctors running our drug trials?” asks Peter Aldhous. Could a biology student in Colombia be jailed for violating copyright?
A 2012 expression of concern prompted by an authorship dispute has been upgraded to a retraction. As we reported in 2012, Revista Brasiliera de Reumatologia (aka the Brazilian Journal of Rheumatology) issued an expression of concern about “Anticitrullinated peptide antibodies and rheumatoid factor in Sudanese patients with Leishmania donovani infection” after a claim from one … Continue reading Bitter rheumatology authorship dispute ends in retraction
A group of researchers in China has lost their paper on liver cancer after the first author admitted to duplication, also known, inelegantly, as self-plagiarism. The paper, “Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells,” appeared in the July 2013 issue of the Journal of Drug … Continue reading “Lack of experience and understanding” forces duplication retractions of liver cancer paper
A Democratic senator from Montana, John Walsh, is the latest high-profile politician to face plagiarism charges. The New York Times reports: …one of the highest-profile credentials of Mr. Walsh’s 33-year military career appears to have been improperly attained. An examination of the final paper required for Mr. Walsh’s master’s degree from the United States Army … Continue reading U.S. senator appears to have plagiarized his master’s thesis
After typing up 96 citations, researchers from the National Institute for Digestive Diseases, I.R.C.C.S. “S. de Bellis,” in Bari, Italy, apparently ran out of steam for the last five, earning themselves a retraction for plagiarism in a literature review of the effects of probiotics on intestinal cancer. Here’s the notice for “Intestinal Microbiota, Probiotics and … Continue reading Yogurt to be kidding me: Five articles plagiarized in one retracted paper
You’ve got to love when an author is willing to detail the specifics of an unhelpful retraction notice. This May, a paper came out in Journal of Thoracic Diseases about drug-resistant tuberculosis. It was retracted in June, for “some misconduct in the manuscript.” Here’s the notice: The article “Application status of MALDI-TOF mass spectrometry in the … Continue reading Author steps in to clarify vague tuberculosis retraction
This story began as a report of a one-off case of potential predatory practice last month, and has escalated to an official call to disband an entire international editorial board, and an accusation against the editor of mass-scale nepotism and other publishing misconduct. The journal, Archives of Biological Sciences (ABS) is the official publication of … Continue reading Serbian journal lands in hot water after challenge on 24 hour peer review that cost 1785 euros
We haven’t covered that many retractions in economics, and a 2012 paper found very few such retractions. Now, a new study based on a survey of economists tries to get a handle on how often economists commit scientific misconduct. Here’s the abstract of “Scientific misbehavior in economics,” which appeared in Research Policy:
Another busy week at Retraction Watch, with Ivan speaking in Vienna, at a PhD student retreat in nearby Zwettl, and in London. The retreat gave rise to “We Will Retract You,” which may just become the Retraction Watch theme song. Watch here. Here’s what was happening elsewhere:
Oncology Reviews has retracted a 2014 paper on breast cancer after learning that the authors lifted parts of it from a continuing medical education lesson on Medscape. The paper, “Challenges of combined everolimus/endocrine therapy in hormone receptor-positive metastatic breast cancer,” was written by Yousif Abubakr, of Thomas Jefferson University in Philadelphia, and Yasar Albushra, of … Continue reading Authors plagiarize CME cancer article, lose their review paper